EIN 98-0590804

Tuberculosis Vaccine Initiative (TBVI)

IRS 501(c) type
501(c)(3)
Num. employees
0
City
Netherlands
State
Year formed
2008
Most recent tax filings
2022-12-01
Description
To support, integrate, translate and prioritise R&D efforts to discover and develop new tuberculosis vaccines that are accessible and affordable for all.
Total revenues
$839,289
2022
Total expenses
$839,289
2022
Total assets
$2,068,439
2022
Num. employees
0
2022

Program areas at TBVI

TBVI mobilises resources and identifies develops and manages projects for TB vaccine R&D with a particular focus on discovery preclinical and early clinical activities. In addition it supports projects for the discovery optimisation and validation of biomarkers. TBVI works with governments foundations and the private sector to increase public funding as well as private sector investment opportunities for R&D of new vaccines.
TBVI supports translation from ideas to tangible products through the advisory services of its Product & Clinical Development Team P&CDT. This team of independent vaccine R&D experts supports TBVI's R&D partners in moving their candidates from discovery to early clinical development. In its strategy TBVI considers the need to: discover and develop safe and effective vaccines for all; prevent infection and transmission of disease; build on the R&D comparative advantage of the TBVI consortium members; make the best use of limited resources and mobilise additional funding.
TBVI brings together the efforts of leading universities government institutes biotech and vaccine companies through TB vaccine and biomarker discovery and development projects. TBVI creates an enabling environment through its knowledge-sharing platform including meetings symposia and workshops and through joint collaborative research that stimulates knowledge exchange and creates synergies among R&D partners and other stakeholders in the field.

Personnel at TBVI

NameTitleCompensation
Dr Francois SpertiniChief - Physician, Centre Hospitalier
Dr Beatrice de Vos, MD, PHDManaging Director
Anne MeinemaFinancial Director / Director Finance and Administration$0
Dr Emmanuele GerdilDirector, Regulatory Affairs Europe
Van RietProjectmanagement$34,755
...and 8 more key personnel

Financials for TBVI

RevenuesFYE 12/2022
Total grants, contributions, etc.$838,504
Program services$0
Investment income and dividends$785
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$839,289

Form 990s for TBVI

Fiscal year endingDate received by IRSFormPDF link
2022-122023-05-11990View PDF
2021-122022-05-09990View PDF
2020-122022-04-15990View PDF
2019-122021-03-26990View PDF
2018-122019-06-20990View PDF
...and 9 more Form 990s
Data update history
July 8, 2023
Posted financials
Added Form 990 for fiscal year 2022
June 30, 2023
Updated personnel
Identified 1 new personnel
June 13, 2023
Posted financials
Added Form 990 for fiscal year 2020
May 16, 2023
Updated personnel
Identified 1 new personnel
July 10, 2022
Used new vendors
Identified 1 new vendor, including
Nonprofit Types
Disease-focused nonprofitsResearch centers
Issues
Science and technologyHealthDiseases and disordersPublic policy
Characteristics
Conducts researchOperates internationallyReceives government fundingNo full-time employees
General information
Address
Runderweg 6
Netherlands, 00000
Website URL
tbvi.eu/ 
Phone
+31 320 277 550
Twitter profile
@tbvi_eu 
IRS details
EIN
98-0590804
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2008
Eligible to receive tax-deductible contributions (Pub 78)
No
Categorization
NTEE code, primary
G80: Specifically Named Diseases
NAICS code, primary
5417: Scientific Research and Development Services
Parent/child status
Independent
Free account sign-up

Want updates when TBVI has new information, or want to find more organizations like Tuberculosis Vaccine Initiative (TBVI)?

Create free Cause IQ account